ArticleScientific reports2025
Comparing large scale and selected feature learning for community acquired pneumonia prognosis prediction using clinical data: a stacked ensemble approach.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and validation of a machine learning-driven framework for differentiating pediatric bronchopneumonia from lobar pneumonia: a multicenter investigation.European journal of medical research · 2025Trial
- Predicting macrolide resistance in pediatric Mycoplasma pneumoniae pneumonia: A machine learning modeling study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Artificial Intelligence Applications in Pneumonia: Diagnosis and Outcome Prediction.Current pulmonology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated and validated all-cause in-hospital death prediction models for hospitalized pneumonia patients based on large-scale clinical data, including diagnoses, medication prescriptions, and laboratory test codes. Feature selection was performed using both large-scale feature learning with a Common Data Model (CDM) and specific pneumonia-related risk factors. A stacked ensemble mixed machine-learning model was compared with traditional machine-learning models. Accuracy, F1-score, the Area Under Precision Recall Curve (AUPRC) and the Area Under the Receiver Operating Characteristic (AUROC) were used for performance evaluation. For large-scale feature learning using a CDM, the ensemble model (LASSO LR + GBM + RF) achieved the highest performance. For the 365-day lookback, the ensemble model's AUROC was 0.867 (95% CI: 0.823-0.910), and for the 7-day lookback (AUROC 0.867, 95% CI: 0.822-0.912). In contrast, for feature learning based on selected pneumonia risk factors, among the traditional models, the RF model performed best with AUROCs of 0.774 (95% CI: 0.717-0.830) for the 365-day lookback and 0.773 (95% CI: 0.717-0.828) for the 7-days lookback. Leveraging large-scale feature learning within the CDM and using a stacked ensemble model predicts more accurately and robustly, highlighting the potential to capture complex relationships among clinical features and improve prognostic assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.